MarkWide Research

Sale!

Aquaculture Healthcare Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: October, 2022
No of Pages: 159
Delivery Format: PDF+Excel

$2,950.00

Aquaculture Healthcare Market Size exceeded USD 869.5 million in 2021 and is projected to grow at over 5.6% CAGR from 2022 to 2028. Emphasis of aquaculture healthcare is increasing owing to rising incidence of various infectious diseases. This can be attributed to the crowded growth conditions and poor quality of nutrition and water.
The COVID-19 pandemic has negatively impacted the operations of several sectors and industries operating within, virtually resulting in an economic decline. Several fishing and aquaculture related activities we noted to be suspended considering the measure for countering the spread of COVID-19 pandemic. Thus, lowered demand of aquaculture produce limited the demand for therapeutic solutions for aquatic animals thereby, hampering the market.
Moreover, several manufacturers operating in the aquaculture healthcare industry have reported significantly reduced workforce, thus negatively impacting the operational capabilities, thereby slowing down the industry growth. Furthermore, logistical challenges attributed to local and national restrictions on the movement of goods and people was noted to increase cost as well as turnaround time.

Rising demand for fish proteins across the world will boost the aquaculture healthcare market growth

Fish is a good source of protein and micronutrients and is consumed all over the world. For instance, in 2018, according to Food and Agriculture Organization (FAO) of the United Nations, about 88 percent of the 179 million tonnes of total fish production was utilized for direct human consumption. Thus, growing demand for quality fish has led to overfishing and depletion of wild fisheries. This is significantly increasing the demand for farmed fish produce. A growing aquaculture market is noted to increase the demand for aquaculture healthcare products in tandem.

Lack of knowledge regarding diseases in aquatic animals may slow the aquaculture healthcare market expansion

Limited awareness surrounding occurrence of diseases and benefits of aquaculture healthcare significantly impacts the industry revenue. This is estimated to be a concerning factor as it can render a sluggish rate of fish production coupled with an increasing rate of death, thereby limiting the market progression.

Focus on healthy fish production will contribute to the expansion of parasiticides segment

The drugs segment valued at USD 469.8 million in 2021 led by the increasing number of parasites in aquaculture. Parasites cause major disease outbreaks in farmed fishes, thereby resulting in a financial loss. Thus, in order to cure parasites, parasiticides are used, augmenting the industry expansion. In addition, growing emphasis on healthy production of fish to increase the economic benefits further fosters the demand of drugs for aquaculture healthcare.

Increasing fish consumption largely influences the segment growth

The fishes segment dominated more than 85.8% of the market share in 2021. Owing to the increasing demand for superior fish protein and the considerable expansion of the aquaculture market, there is a massive need for aquaculture healthcare solutions, thereby fuelling the industry progression. Additionally, rising fish farming is one of the major factors contributing to the market value.

Growing prevalence of bacterial diseases will spur the market revenue

The bacterial infections segment in the aquaculture healthcare market is predicted to showcase 5.4% growth rate through 2028. Farmed fishes show an increased incidence of bacterial infections in the market. This increased incidence is the result of crowded conditions in fish farms. Furthermore, poor sanitation, poor water quality and nutritional value result in increased susceptibility to bacteria.

Ease of use will bolster the expansion of oral therapeutics segment

 The injectable segment accounted for 56% of revenue share in 2021 impelled by the effectiveness of injectable therapeutics. Drug diffusion varies due to the irregularity of metabolic processes in fish credited to their poikilothermic nature and poorly vascularized tissues. Injectable products offer direct delivery of antigen into muscle or body cavity, allowing rapid stimulation of immune response.

Distributors will see substantial growth owing to growing agreements with the manufacturers

Distributors segment crossed USD 348.5 million in 2021. Numerous manufacturers are noted to partner with distributors to strengthen their geographic presence, market penetration and product visibility. Moreover, third-party distributors have a widespread network in various developing and developed markets.

Rising research and development investment to propel the growth for North America region

North America aquaculture healthcare market held 10.4% of revenue share in 2021 and is poised to attain a CAGR of 5.8% till 2028. Increasing research and development investment by major players such as Zoetis Inc. and Merck & Co. is fuelling the market expansion. Moreover, the availability of diverse range of aquaculture healthcare solutions in the country will further stimulate the industry value. Furthermore, rising demand of fish food in the region will accelerate the demand for farmed fishes, further driving the demand for aquaculture healthcare products.

Organic and inorganic growth strategies adopted by leading players will enhance the market growth

Major companies operating in the market are Elanco, Zoetis, Vetoquinol, Ceva Sante, Benchmark PLC, and Archer Daniels Midland Corporation. The key leaders are focusing on research & development to launch innovative aquaculture healthcare products. Strategic acquisitions remain another strategy to expand their customer base.

The aquaculture healthcare market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028, for the following segments:

Market, By Product

  • Drug
    • Parasiticides
    • Anti-inflammatory
    • Anti-infectives
    • Others
  • Vaccines
    • Modified live vaccines [MLV]
    • Killed inactivated vaccines
    • Others
  • Medicated feed additives
    • Antibiotics
    • Vitamins
    • Amino acids
    • Enzymes
    • Antioxidants
    • Prebiotics and probiotics
    • Minerals
    • Hormones
    • Others

Market, By Species

  • Fishes
    • Freshwater Species
      • Tilapia
      • Carps
      • Others
    • Marine Species
      • Sea bass
      • Sea bream
      • Turbot
      • Others
    • Diadromous Species
      • Salmon
      • Trout
      • Others
  • Crustaceans
    • Prawns
    • Shrimps
    • Others

Market, By Infections

  • Bacterial infections
  • Viral infections
  • Parasitic infections
  • Fungal infections

Market, By Route of Administration

  • Oral
  • Injectable
  • Topical

Market, By Distribution Channel

  • Distributors
  • Online stores
  • Retail/aqua stores
  • Others

The above information is provided for the following geographies:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Denmark
    • Iceland
    • Ireland
    • Norway
    • Poland
    • Turkey
    • Others
  • Asia Pacific
    • China
    • Vietnam
    • Indonesia
    • India
    • Thailand
    • Bangladesh
    • Philippines
    • Australia
    • New Zealand
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Chile
    • Others
  • Middle East and Africa
    • Iran
    • Egypt
    • Others

Chapter 1   Methodology

1.1    Methodology

1.2    Market definitions

1.3    Forecast parameters

1.4    Data source

1.4.1    Secondary

1.4.1.1    Paid sources

1.4.1.2    Unpaid sources

1.4.2    Primary

Chapter 2   Executive Summary

2.1    Aquaculture healthcare industry 3600 synopsis, 2017-2028

2.1.1    Business trends

2.1.2    Product trends

2.1.3    Species trends

2.1.4    Infection trends

2.1.5    Route of administration trends

2.1.6    Distribution channel trends

2.1.7    Regional trends

Chapter 3   Aquaculture Healthcare Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2017-2028

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Increasing demand for fish protein across the world

3.3.1.2    Growing incidence of diseases and parasites in farmed fish

3.3.1.3    Growing R&D efforts by key market players to bring new solutions for aquaculture healthcare

3.3.2    Industry pitfalls & challenges

3.3.2.1    Aversion to farmed fish due to health concerns

3.3.2.2    Lack of knowledge regarding diseases in aquatic animals

3.3.2.3    Concerns over growing antibiotic resistance due to widespread use

3.4    Growth potential analysis

3.4.1    By product

3.4.2    By species

3.4.3    By infection

3.4.4    By route of administration

3.4.5    By distribution channel

3.5    Porter’s analysis

3.6    Competitive landscape, 2021

3.6.1    Company share analysis, 2021

3.6.2    Competitive matrix analysis

3.7    PESTEL analysis

Chapter 4   Aquaculture Healthcare Market, By Product

4.1    Key segment trends

4.2    Drugs

4.2.1    Market size, by region, 2017-2028 (USD Million)

4.2.2    Parasiticides

4.2.2.1    Market size, by region, 2017-2028 (USD Million)

4.2.3    Anti-inflammatory

4.2.3.1    Market size, by region, 2017-2028 (USD Million)

4.2.4    Anti-infectives

4.2.4.1    Market size, by region, 2017-2028 (USD Million)

4.2.5    Others

4.2.5.1    Market size, by region, 2017-2028 (USD Million)

4.3    Vaccines

4.3.1    Market size, by region, 2017-2028 (USD Million)

4.3.2    Modified live vaccines [MLV]

4.3.2.1    Market size, by region, 2017-2028 (USD Million)

4.3.3    Killed inactivated vaccines

4.3.3.1    Market size, by region, 2017-2028 (USD Million)

4.3.4    Others

4.3.4.1    Market size, by region, 2017-2028 (USD Million)

4.4    Feed additives

4.4.1    Market size, by region, 2017-2028 (USD Million)

4.4.2    Antibiotics

4.4.2.1    Market size, by region, 2017-2028 (USD Million)

4.4.3    Vitamins

4.4.3.1    Market size, by region, 2017-2028 (USD Million)

4.4.4    Amino acids

4.4.4.1    Market size, by region, 2017-2028 (USD Million)

4.4.5    Enzymes

4.4.5.1    Market size, by region, 2017-2028 (USD Million)

4.4.6    Antioxidants

4.4.6.1    Market size, by region, 2017-2028 (USD Million)

4.4.7    Prebiotics and probiotics

4.4.7.1    Market size, by region, 2017-2028 (USD Million)

4.4.8    Minerals

4.4.8.1    Market size, by region, 2017-2028 (USD Million)

4.4.9    Hormones

4.4.9.1    Market size, by region, 2017-2028 (USD Million)

4.4.10    Others

4.4.10.1    Market size, by region, 2017-2028 (USD Million)

Chapter 5   Aquaculture Healthcare Market, By Species

5.1    Key segment trends

5.2    Fishes

5.2.1    Market size, by region, 2017-2028 (USD Million)

5.2.2    Freshwater species

5.2.2.1    Market size, by region, 2017-2028 (USD Million)

5.2.2.2    Tilapia

5.2.2.2.1    Market size, by region, 2017-2028 (USD Million)

5.2.2.3    Carps

5.2.2.3.1    Market size, by region, 2017-2028 (USD Million)

5.2.2.4    Others

5.2.2.4.1    Market size, by region, 2017-2028 (USD Million)

5.2.3    Marine species

5.2.3.1    Market size, by region, 2017-2028 (USD Million)

5.2.3.2    Seabass seabream

5.2.3.2.1    Market size, by region, 2017-2028 (USD Million)

5.2.3.3    Turbot

5.2.3.3.1    Market size, by region, 2017-2028 (USD Million)

5.2.3.4    Others

5.2.3.4.1    Market size, by region, 2017-2028 (USD Million)

5.2.4    Diadromous species

5.2.4.1    Market size, by region, 2017-2028 (USD Million)

5.2.4.2    Salmon

5.2.4.2.1    Market size, by region, 2017-2028 (USD Million)

5.2.4.3    Trout

5.2.4.3.1    Market size, by region, 2017-2028 (USD Million)

5.2.4.4    Others

5.2.4.4.1    Market size, by region, 2017-2028 (USD Million)

5.3    Crustaceans

5.3.1    Market size, by region, 2017-2028 (USD Million)

5.3.2    Prawns

5.3.2.1    Market size, by region, 2017-2028 (USD Million)

5.3.3    Shrimps

5.3.3.1    Market size, by region, 2017-2028 (USD Million)

5.3.4    Others

5.3.4.1    Market size, by region, 2017-2028 (USD Million)

5.4    Others

5.4.1    Market size, by region, 2017-2028 (USD Million)

Chapter 6   Aquaculture Healthcare Market, By Infection

6.1    Key segment trends

6.2    Bacterial infection

6.2.1    Market size, by region, 2017-2028 (USD Million)

6.3    Viral infection

6.3.1    Market size, by region, 2017-2028 (USD Million)

6.4    Parasitic infection

6.4.1    Market size, by region, 2017-2028 (USD Million)

6.5    Fungal infection

6.5.1    Market size, by region, 2017-2028 (USD Million)

Chapter 7   Aquaculture Healthcare Market, By Route of Administration

7.1    Key segment trends

7.2    Oral

7.2.1    Market size, by region, 2017-2028 (USD Million)

7.3    Injectable

7.3.1    Market size, by region, 2017-2028 (USD Million)

7.4    Topical

7.4.1    Market size, by region, 2017-2028 (USD Million)

Chapter 8   Aquaculture Healthcare Market, By Distribution Channel

8.1    Key segment trends

8.2    Distributors

8.2.1    Market size, by region, 2017-2028 (USD Million)

8.3    Online stores

8.3.1    Market size, by region, 2017-2028 (USD Million)

8.4    Retail/Aqua stores

8.4.1    Market size, by region, 2017-2028 (USD Million)

8.5    Others

8.5.1    Market size, by region, 2017-2028 (USD Million)

Chapter 9   Aquaculture Healthcare Market, By Region

9.1    Key regional trends

9.2    North America

9.2.1    Market size, by country, 2017-2028 (USD Million)

9.2.2    Market size, by product, 2017-2028 (USD Million)

9.2.2.1    Market size, by drugs, 2017-2028 (USD Million)

9.2.2.2    Market size, by vaccines, 2017-2028 (USD Million)

9.2.2.3    Market size, by medicated feed additives, 2017-2028 (USD Million)

9.2.3    Market size, by species, 2017-2028 (USD Million)

9.2.3.1    Market size, by fishes, 2017-2028 (USD Million)

9.2.3.1.1    Market size, by freshwater species, 2017-2028 (USD Million)

9.2.3.1.2    Market size, by diadromous species, 2017-2028 (USD Million)

9.2.3.2    Market size, by crustaceans, 2017-2028 (USD Million)

9.2.4    Market size, by infection, 2017-2028 (USD Million)

9.2.5    Market size, by route of administration, 2017-2028 (USD Million)

9.2.6    Market size, by distribution channel, 2017-2028 (USD Million)

9.2.7    U.S.

9.2.7.1    Market size, by product, 2017-2028 (USD Million)

9.2.7.1.1    Market size, by drugs, 2017-2028 (USD Million)

9.2.7.1.2    Market size, by vaccines, 2017-2028 (USD Million)

9.2.7.1.3    Market size, by medicated feed additives, 2017-2028 (USD Million)

9.2.7.2    Market size, by species, 2017-2028 (USD Million)

9.2.7.2.1    Market size, by fishes, 2017-2028 (USD Million)

9.2.7.2.1.1    Market size, by freshwater species, 2017-2028 (USD Million)

9.2.7.2.1.2    Market size, by diadromous species, 2017-2028 (USD Million)

9.2.7.2.2    Market size, by crustaceans, 2017-2028 (USD Million)

9.2.7.3    Market size, by infection, 2017-2028 (USD Million)

9.2.7.4    Market size, by route of administration, 2017-2028 (USD Million)

9.2.7.5    Market size, by distribution channel, 2017-2028 (USD Million)

9.2.8    Canada

9.2.8.1    Market size, by product, 2017-2028 (USD Million)

9.2.8.2    Market size, by drugs, 2017-2028 (USD Million)

9.2.8.3    Market size, by vaccines, 2017-2028 (USD Million)

9.2.8.4    Market size, by medicated feed additives, 2017-2028 (USD Million)

9.2.8.5    Market size, by species, 2017-2028 (USD Million)

9.2.8.5.1    Market size, by fishes, 2017-2028 (USD Million)

9.2.8.5.1.1    Market size, by diadromous species, 2017-2028 (USD Million)

9.2.8.6    Market size, by infection, 2017-2028 (USD Million)

9.2.8.7    Market size, by route of administration, 2017-2028 (USD Million)

9.2.8.8    Market size, by distribution channel, 2017-2028 (USD Million)

9.3    Europe

9.3.1    Market size, by country, 2017-2028 (USD Million)

9.3.2    Market size, by product, 2017-2028 (USD Million)

9.3.2.1    Market size, by drugs, 2017-2028 (USD Million)

9.3.2.2    Market size, by vaccines, 2017-2028 (USD Million)

9.3.2.3    Market size, by medicated feed additives, 2017-2028 (USD Million)

9.3.3    Market size, by species, 2017-2028 (USD Million)

9.3.3.1    Market size, by fishes, 2017-2028 (USD Million)

9.3.3.1.1    Market size, by freshwater species, 2017-2028 (USD Million)

9.3.3.1.2    Market size, by marine species, 2017-2028 (USD Million)

9.3.3.1.3    Market size, by diadromous species, 2017-2028 (USD Million)

9.3.4    Market size, by infection, 2017-2028 (USD Million)

9.3.5    Market size, by route of administration, 2017-2028 (USD Million)

9.3.6    Market size, by distribution channel, 2017-2028 (USD Million)

9.3.7    Germany

9.3.7.1    Market size, by product, 2017-2028 (USD Million)

9.3.7.2    Market size, by drugs, 2017-2028 (USD Million)

9.3.7.3    Market size, by vaccines, 2017-2028 (USD Million)

9.3.7.4    Market size, by medicated feed additives, 2017-2028 (USD Million)

9.3.7.5    Market size, by species, 2017-2028 (USD Million)

9.3.7.5.1    Market size, by fishes, 2017-2028 (USD Million)

9.3.7.5.1.1    Market size, by freshwater species, 2017-2028 (USD Million)

9.3.7.5.1.2    Market size, by marine species, 2017-2028 (USD Million)

9.3.7.5.1.3    Market size, by diadromous species, 2017-2028 (USD Million)

9.3.7.6    Market size, by infection, 2017-2028 (USD Million)

9.3.7.7    Market size, by route of administration, 2017-2028 (USD Million)

9.3.7.8    Market size, by distribution channel, 2017-2028 (USD Million)

9.3.8    UK

9.3.8.1    Market size, by product, 2017-2028 (USD Million)

9.3.8.2    Market size, by drugs, 2017-2028 (USD Million)

9.3.8.3    Market size, by vaccines, 2017-2028 (USD Million)

9.3.8.4    Market size, by medicated feed additives, 2017-2028 (USD Million)

9.3.8.5    Market size, by species, 2017-2028 (USD Million)

9.3.8.5.1    Market size, by fishes, 2017-2028 (USD Million)

9.3.8.5.1.1    Market size, by diadromous species, 2017-2028 (USD Million)

9.3.8.6    Market size, by infection, 2017-2028 (USD Million)

9.3.8.7    Market size, by route of administration, 2017-2028 (USD Million)

9.3.8.8    Market size, by distribution channel, 2017-2028 (USD Million)

9.3.9    France

9.3.9.1    Market size, by product, 2017-2028 (USD Million)

9.3.9.2    Market size, by drugs, 2017-2028 (USD Million)

9.3.9.3    Market size, by vaccines, 2017-2028 (USD Million)

9.3.9.4    Market size, by medicated feed additives, 2017-2028 (USD Million)

9.3.9.5    Market size, by species, 2017-2028 (USD Million)

9.3.9.5.1    Market size, by fishes, 2017-2028 (USD Million)

9.3.9.5.1.1    Market size, by freshwater species, 2017-2028 (USD Million)

9.3.9.5.1.2    Market size, by marine species, 2017-2028 (USD Million)

9.3.9.5.1.3    Market size, by diadromous species, 2017-2028 (USD Million)

9.3.9.6    Market size, by infection, 2017-2028 (USD Million)

9.3.9.7    Market size, by route of administration, 2017-2028 (USD Million)

9.3.9.8    Market size, by distribution channel, 2017-2028 (USD Million)

9.3.10    Spain

9.3.10.1    Market size, by product, 2017-2028 (USD Million)

9.3.10.2    Market size, by drugs, 2017-2028 (USD Million)

9.3.10.3    Market size, by vaccines, 2017-2028 (USD Million)

9.3.10.4    Market size, by medicated feed additives, 2017-2028 (USD Million)

9.3.10.5    Market size, by species, 2017-2028 (USD Million)

9.3.10.5.1    Market size, by fishes, 2017-2028 (USD Million)

9.3.10.5.1.1    Market size, by marine species, 2017-2028 (USD Million)

9.3.10.5.1.2    Market size, by diadromous species, 2017-2028 (USD Million)

9.3.10.6    Market size, by infection, 2017-2028 (USD Million)

9.3.10.7    Market size, by route of administration, 2017-2028 (USD Million)

9.3.10.8    Market size, by distribution channel, 2017-2028 (USD Million)

9.3.11    Italy

9.3.11.1    Market size, by product, 2017-2028 (USD Million)

9.3.11.2    Market size, by drugs, 2017-2028 (USD Million)

9.3.11.3    Market size, by vaccines, 2017-2028 (USD Million)

9.3.11.4    Market size, by medicated feed additives, 2017-2028 (USD Million)

9.3.11.5    Market size, by species, 2017-2028 (USD Million)

9.3.11.5.1    Market size, by fishes, 2017-2028 (USD Million)

9.3.11.5.1.1    Market size, by marine species, 2017-2028 (USD Million)

9.3.11.5.1.2    Market size, by diadromous species, 2017-2028 (USD Million)

9.3.11.6    Market size, by infection, 2017-2028 (USD Million)

9.3.11.7    Market size, by route of administration, 2017-2028 (USD Million)

9.3.11.8    Market size, by distribution channel, 2017-2028 (USD Million)

9.3.12    Demark

9.3.12.1    Market size, by product, 2017-2028 (USD Million)

9.3.12.2    Market size, by drugs, 2017-2028 (USD Million)

9.3.12.3    Market size, by vaccines, 2017-2028 (USD Million)

9.3.12.4    Market size, by medicated feed additives, 2017-2028 (USD Million)

9.3.12.5    Market size, by species, 2017-2028 (USD Million)

9.3.12.5.1    Market size, by fishes, 2017-2028 (USD Million)

9.3.12.5.1.1    Market size, by diadromous species, 2017-2028 (USD Million)

9.3.12.6    Market size, by infection, 2017-2028 (USD Million)

9.3.12.7    Market size, by route of administration, 2017-2028 (USD Million)

9.3.12.8    Market size, by distribution channel, 2017-2028 (USD Million)

9.3.13    Iceland

9.3.13.1    Market size, by product, 2017-2028 (USD Million)

9.3.13.2    Market size, by drugs, 2017-2028 (USD Million)

9.3.13.3    Market size, by vaccines, 2017-2028 (USD Million)

9.3.13.4    Market size, by medicated feed additives, 2017-2028 (USD Million)

9.3.13.5    Market size, by species, 2017-2028 (USD Million)

9.3.13.5.1    Market size, by fishes, 2017-2028 (USD Million)

9.3.13.5.1.1    Market size, by diadromous species, 2017-2028 (USD Million)

9.3.13.6    Market size, by infection, 2017-2028 (USD Million)

9.3.13.7    Market size, by route of administration, 2017-2028 (USD Million)

9.3.13.8    Market size, by distribution channel, 2017-2028 (USD Million)

9.3.14    Ireland

9.3.14.1    Market size, by product, 2017-2028 (USD Million)

9.3.14.2    Market size, by drugs, 2017-2028 (USD Million)

9.3.14.3    Market size, by vaccines, 2017-2028 (USD Million)

9.3.14.4    Market size, by medicated feed additives, 2017-2028 (USD Million)

9.3.14.5    Market size, by species, 2017-2028 (USD Million)

9.3.14.5.1    Market size, by fishes, 2017-2028 (USD Million)

9.3.14.5.1.1    Market size, by diadromous species, 2017-2028 (USD Million)

9.3.14.6    Market size, by infection, 2017-2028 (USD Million)

9.3.14.7    Market size, by route of administration, 2017-2028 (USD Million)

9.3.14.8    Market size, by distribution channel, 2017-2028 (USD Million)

9.3.15    Norway

9.3.15.1    Market size, by product, 2017-2028 (USD Million)

9.3.15.2    Market size, by drugs, 2017-2028 (USD Million)

9.3.15.3    Market size, by vaccines, 2017-2028 (USD Million)

9.3.15.4    Market size, by medicated feed additives, 2017-2028 (USD Million)

9.3.15.5    Market size, by species, 2017-2028 (USD Million)

9.3.15.5.1    Market size, by fishes, 2017-2028 (USD Million)

9.3.15.5.1.1    Market size, by diadromous species, 2017-2028 (USD Million)

9.3.15.6    Market size, by infection, 2017-2028 (USD Million)

9.3.15.7    Market size, by route of administration, 2017-2028 (USD Million)

9.3.15.8    Market size, by distribution channel, 2017-2028 (USD Million)

9.3.16    Poland

9.3.16.1    Market size, by product, 2017-2028 (USD Million)

9.3.16.2    Market size, by drugs, 2017-2028 (USD Million)

9.3.16.3    Market size, by vaccines, 2017-2028 (USD Million)

9.3.16.4    Market size, by medicated feed additives, 2017-2028 (USD Million)

9.3.16.5    Market size, by species, 2017-2028 (USD Million)

9.3.16.5.1    Market size, by fishes, 2017-2028 (USD Million)

9.3.16.5.1.1    Market size, by freshwater species, 2017-2028 (USD Million)

9.3.16.5.1.2    Market size, by marine species, 2017-2028 (USD Million)

9.3.16.5.1.3    Market size, by diadromous species, 2017-2028 (USD Million)

9.3.16.6    Market size, by infection, 2017-2028 (USD Million)

9.3.16.7    Market size, by route of administration, 2017-2028 (USD Million)

9.3.16.8    Market size, by distribution channel, 2017-2028 (USD Million)

9.3.17    Turkey

9.3.17.1    Market size, by product, 2017-2028 (USD Million)

9.3.17.2    Market size, by drugs, 2017-2028 (USD Million)

9.3.17.3    Market size, by vaccines, 2017-2028 (USD Million)

9.3.17.4    Market size, by medicated feed additives, 2017-2028 (USD Million)

9.3.17.5    Market size, by species, 2017-2028 (USD Million)

9.3.17.5.1    Market size, by fishes, 2017-2028 (USD Million)

9.3.17.5.1.1    Market size, by marine species, 2017-2028 (USD Million)

9.3.17.5.1.2    Market size, by diadromous species, 2017-2028 (USD Million)

9.3.17.6    Market size, by infection, 2017-2028 (USD Million)

9.3.17.7    Market size, by route of administration, 2017-2028 (USD Million)

9.3.17.8    Market size, by distribution channel, 2017-2028 (USD Million)

9.4    Asia Pacific

9.4.1    Market size, by country, 2017-2028 (USD Million)

9.4.2    Market size, by product, 2017-2028 (USD Million)

9.4.2.1    Market size, by drugs, 2017-2028 (USD Million)

9.4.2.2    Market size, by vaccines, 2017-2028 (USD Million)

9.4.2.3    Market size, by medicated feed additives, 2017-2028 (USD Million)

9.4.3    Market size, by species, 2017-2028 (USD Million)

9.4.3.1    Market size, by fishes, 2017-2028 (USD Million)

9.4.3.1.1    Market size, by freshwater species, 2017-2028 (USD Million)

9.4.3.1.2    Market size, by marine species, 2017-2028 (USD Million)

9.4.3.1.3    Market size, by diadromous species, 2017-2028 (USD Million)

9.4.3.2    Market size, by crustaceans, 2017-2028 (USD Million)

9.4.4    Market size, by infection, 2017-2028 (USD Million)

9.4.5    Market size, by route of administration, 2017-2028 (USD Million)

9.4.6    Market size, by distribution channel, 2017-2028 (USD Million)

9.4.7    China

9.4.7.1    Market size, by product, 2017-2028 (USD Million)

9.4.7.2    Market size, by drugs, 2017-2028 (USD Million)

9.4.7.3    Market size, by vaccines, 2017-2028 (USD Million)

9.4.7.4    Market size, by medicated feed additives, 2017-2028 (USD Million)

9.4.7.5    Market size, by species, 2017-2028 (USD Million)

9.4.7.5.1    Market size, by fishes, 2017-2028 (USD Million)

9.4.7.5.1.1    Market size, by freshwater species, 2017-2028 (USD Million)

9.4.7.5.1.2    Market size, by marine species, 2017-2028 (USD Million)

9.4.7.5.1.3    Market size, by diadromous species, 2017-2028 (USD Million)

9.4.7.5.2    Market size, by crustaceans, 2017-2028 (USD Million)

9.4.7.6    Market size, by infection, 2017-2028 (USD Million)

9.4.7.7    Market size, by route of administration, 2017-2028 (USD Million)

9.4.7.8    Market size, by distribution channel, 2017-2028 (USD Million)

9.4.8    Vietnam

9.4.8.1    Market size, by product, 2017-2028 (USD Million)

9.4.8.2    Market size, by drugs, 2017-2028 (USD Million)

9.4.8.3    Mark

Market, By Product

  • Drug
    • Parasiticides
    • Anti-inflammatory
    • Anti-infectives
    • Others
  • Vaccines
    • Modified live vaccines [MLV]
    • Killed inactivated vaccines
    • Others
  • Medicated feed additives
    • Antibiotics
    • Vitamins
    • Amino acids
    • Enzymes
    • Antioxidants
    • Prebiotics and probiotics
    • Minerals
    • Hormones
    • Others

Market, By Species

  • Fishes
    • Freshwater Species
      • Tilapia
      • Carps
      • Others
    • Marine Species
      • Sea bass
      • Sea bream
      • Turbot
      • Others
    • Diadromous Species
      • Salmon
      • Trout
      • Others
  • Crustaceans
    • Prawns
    • Shrimps
    • Others

Market, By Infections

  • Bacterial infections
  • Viral infections
  • Parasitic infections
  • Fungal infections

Market, By Route of Administration

  • Oral
  • Injectable
  • Topical

Market, By Distribution Channel

  • Distributors
  • Online stores
  • Retail/aqua stores
  • Others

Elanco, Zoetis, Vetoquinol, Ceva Sante, Benchmark PLC, and Archer Daniels Midland Corporation.

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF